This Wednesday (Feb 15th), I will attend the OurCrowd summit in Jerusalem.
Happy to meet and discuss with individuals and potential Investors who are interested in NurExone Biologic‘s unique therapy and technology platform to treat damage in the Central Nervous System (#CNS) with the potential to treat Spinal Cord Injuries (#SCI).